Repurposing Atomoxetine for Neuroprotection in MCI

Atomoxetine, approved for ADHD, can be repurposed as a safe and effective therapy for mild cognitive impairment and improves multiple biomarkers of Alzheimer’s disease, according to this study.

Read the full article here

Related Articles